Bicycle Therapeutics appoints new chief medical officer
27 September 2017
Biotech firm Bicycle Therapeutics has appointed a new chief medical officer, Maria Koehler, a former VP in oncology at Pfizer.
At Pfizer, Dr Koehler led development strategies for Ibrance (palbociclib), which was launched in 2015.
Dr Koehler was previously at GlaxoSmithKline and AstraZeneca, where she held clinical development roles in oncology.
The author of more than 160 peer reviewed publications and book chapters, Dr Koehler received her MD and PhD from the Silesian School of Medicine in Katowice, Poland.
More on this story...
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze